New Cell Model for Testing Treatments for Neurodegeneration
Author Information
Author(s): Alessandro Giustini, Alice Maiocchi, Ilaria Serangeli, Martina Pedrini, Anna Quintiliani, Valentina Sabato, Francesca Bonato, Pierfausto Seneci, Giuseppe Lupo, Daniele Passarella, Elena Miranda
Primary Institution: Sapienza University of Rome
Hypothesis
Can a new cellular system be developed to test small molecules that reduce neuroserpin polymer formation in FENIB?
Conclusion
The study successfully created a novel cell culture model for FENIB that can be used to test therapeutic strategies.
Supporting Evidence
- The study created a cell model that allows for controlled expression of neuroserpin.
- PROTAC compounds were tested for their ability to enhance degradation of neuroserpin.
- The model recapitulates the handling of neuroserpin observed in previous studies.
Takeaway
Researchers made a new type of cell that helps them test medicines for a brain disease called FENIB, which currently has no cure.
Methodology
The study involved creating neural stem progenitor cell lines with inducible expression of neuroserpin variants and testing the effects of PROTAC compounds on these cells.
Limitations
The study did not find significant effects of the PROTAC compounds on NS degradation, which may be due to issues with compound solubility or binding efficiency.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website